Working… Menu
Trial record 13 of 75 for:    stem cell peripheral arterial disease AND Arterial Disease

Efficiency, Safety and Portability of Neovasculgen (Neovasculgen)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03068585
Recruitment Status : Completed
First Posted : March 3, 2017
Last Update Posted : March 3, 2017
Information provided by (Responsible Party):
Human Stem Cell Institute, Russia